Increasing localized access can provide faster results for patients while potentially improving patient outcomes Agreement aims to enable greater access to localized advanced testing capabilities for ...

The prenatal and newborn genetic testing market is expanding due to technological advancements in non-invasive methods, rising awareness of genetic disorders, and supportive policies. Key ...

The new technology delivers results in as little as 30 hours and reduces hands-on time by up to 40 percent, according to the company's data.

Residual DNA Testing is vital in detecting trace DNA post-biological processes, crucial for safety across biotechnology, pharmaceuticals, and forensics. It ensures biopharmaceuticals like vaccines are ...

This opinion piece was co-authored by Maya Wang, acting China Director at Human Rights Watch, and Yves Moreau, professor of bioinformatics at the University of Leuven, Belgium. The U.S. biomedical ...

Thermo Fisher Scientific is closing its Carlsbad DNA manufacturing site less than three years after opening it, a move that will mean the loss of more than 70 local jobs. In July 2021, Thermo Fisher ...

WASHINGTON — A U.S. biotech company has halted sales of its DNA testing products in the Chinese ethnic region of Tibet, as lawmakers mull export controls to keep Beijing from using American products ...

CARLSBAD, Calif.--(BUSINESS WIRE)--As part of a global, multiyear agreement, Thermo Fisher Scientific today announced it is working with AstraZeneca to develop a solid tissue and blood-based companion ...